Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages
- PMID: 24260507
- PMCID: PMC3829941
- DOI: 10.1371/journal.pone.0080908
Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages
Abstract
Macrophage polarization is increasingly recognised as an important pathogenetic factor in inflammatory and neoplastic diseases. Proinflammatory M1 macrophages promote T helper (Th) 1 responses and show tumoricidal activity. M2 macrophages contribute to tissue repair and promote Th2 responses. CD68 and CD163 are used to identify macrophages in tissue sections. However, characterisation of polarised macrophages in situ has remained difficult. Macrophage polarisation is regulated by transcription factors, pSTAT1 and RBP-J for M1, and CMAF for M2. We reasoned that double-labelling immunohistochemistry for the detection of macrophage markers together with transcription factors may be suitable to characterise macrophage polarisation in situ. To test this hypothesis, we have studied conditions associated with Th1- and Th2-predominant immune responses: infectious mononucleosis and Crohn's disease for Th1 and allergic nasal polyps, oxyuriasis, wound healing and foreign body granulomas for predominant Th2 response. In all situations, CD163+ cells usually outnumbered CD68+ cells. Moreover, CD163+ cells, usually considered as M2 macrophages, co-expressing pSTAT1 and RBP-J were found in all conditions examined. The numbers of putative M1 macrophages were higher in Th1- than in Th2-associated diseases, while more M2 macrophages were seen in Th2- than in Th1 related disorders. In most Th1-related diseases, the balance of M1 over M2 cells was shifted towards M1 cells, while the reverse was observed for Th2-related conditions. Hierarchical cluster analysis revealed two distinct clusters: cluster I included Th1 diseases together with cases with high numbers of CD163+pSTAT1+, CD68+pSTAT1+, CD163+RBP-J+ and CD68+RBP-J+ macrophages; cluster II comprised Th2 conditions together with cases displaying high numbers of CD163+CMAF+ and CD68+CMAF+ macrophages. These results suggest that the detection of pSTAT1, RBP-J, and CMAF in the context of CD68 or CD163 expression is a suitable tool for the characterisation of macrophage polarisation in situ. Furthermore, CD163 cannot be considered a reliable M2 marker when used on its own.
Conflict of interest statement
Figures
Similar articles
-
Macrophage polarization reflects T cell composition of tumor microenvironment in pediatric classical Hodgkin lymphoma and has impact on survival.PLoS One. 2015 May 15;10(5):e0124531. doi: 10.1371/journal.pone.0124531. eCollection 2015. PLoS One. 2015. PMID: 25978381 Free PMC article.
-
Tumor-associated macrophages in oral premalignant lesions coexpress CD163 and STAT1 in a Th1-dominated microenvironment.BMC Cancer. 2015 Aug 5;15:573. doi: 10.1186/s12885-015-1587-0. BMC Cancer. 2015. PMID: 26242181 Free PMC article.
-
M2-Polarized Macrophages Determine Human Cutaneous Lesions in Lacaziosis.Mycopathologia. 2020 Jun;185(3):477-483. doi: 10.1007/s11046-020-00450-z. Epub 2020 May 6. Mycopathologia. 2020. PMID: 32378114 Free PMC article.
-
CD163 and its role in inflammation.Folia Histochem Cytobiol. 2011;49(3):365-74. doi: 10.5603/fhc.2011.0052. Folia Histochem Cytobiol. 2011. PMID: 22038213 Review.
-
The Role of M1/M2 Macrophage Polarization in Rheumatoid Arthritis Synovitis.Front Immunol. 2022 May 19;13:867260. doi: 10.3389/fimmu.2022.867260. eCollection 2022. Front Immunol. 2022. PMID: 35663975 Free PMC article. Review.
Cited by
-
The Role of Soluble CD163 (sCD163) in Human Physiology and Pathophysiology.Cells. 2024 Oct 11;13(20):1679. doi: 10.3390/cells13201679. Cells. 2024. PMID: 39451197 Free PMC article. Review.
-
Histologic Characterization of Tumor-Adjacent Mammary Adipose Tissue in Normal-Weight and Overweight/Obese Patients with Triple-Negative Breast Cancer.Cancers (Basel). 2024 Oct 17;16(20):3515. doi: 10.3390/cancers16203515. Cancers (Basel). 2024. PMID: 39456610 Free PMC article.
-
Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer.Clin Cancer Res. 2021 Aug 15;27(16):4574-4586. doi: 10.1158/1078-0432.CCR-21-1047. Epub 2021 Jun 10. Clin Cancer Res. 2021. PMID: 34112709 Free PMC article. Clinical Trial.
-
Much More than M1 and M2 Macrophages, There are also CD169(+) and TCR(+) Macrophages.Front Immunol. 2015 May 26;6:263. doi: 10.3389/fimmu.2015.00263. eCollection 2015. Front Immunol. 2015. PMID: 26074923 Free PMC article. Review.
-
Cellular and morphological changes with EAA supplementation before and after total knee arthroplasty.J Appl Physiol (1985). 2019 Aug 1;127(2):531-545. doi: 10.1152/japplphysiol.00869.2018. Epub 2019 Jul 25. J Appl Physiol (1985). 2019. PMID: 31343947 Free PMC article.
References
-
- Janeway C (2005) Immunobiology : the immune system in health and disease. xxiii. New York: Garland Publishing House Science. 823 pp.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous